This may have been factored in to a large degree already be some if you payed close enough attention since the data was out and ABBV had BTD by the FDA. (Personally it was not on my radar at all ) Also the US approval accounts for half of my back of the envelope calculation I just assume ROW will follow in due course Of course we’re trying to make sense of the reaction to the news based on a stock price that to me hasn’t made much sense in a long time so ..
Market Data 
Markets 
AI
